EyePoint Pharmaceuticals, Inc. (EYPT): Price and Financial Metrics


EyePoint Pharmaceuticals, Inc. (EYPT)

Today's Latest Price: $0.46 USD

0.01 (-2.07%)

Updated Oct 23 4:00pm

Add EYPT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

EYPT Stock Summary

  • EyePoint Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 92.18% of US listed stocks.
  • As for revenue growth, note that EYPT's revenue has grown 87.27% over the past 12 months; that beats the revenue growth of 93.9% of US companies in our set.
  • In terms of volatility of its share price, EYPT is more volatile than 90.69% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to EyePoint Pharmaceuticals Inc, a group of peers worth examining would be ZIXI, AUTO, BDR, PAR, and RMTI.
  • EYPT's SEC filings can be seen here. And to visit EyePoint Pharmaceuticals Inc's official web site, go to eyepointpharma.com.

EYPT Stock Price Chart Interactive Chart >

Price chart for EYPT

EYPT Price/Volume Stats

Current price $0.46 52-week high $2.53
Prev. close $0.47 52-week low $0.46
Day low $0.46 Volume 960,200
Day high $0.48 Avg. volume 1,359,131
50-day MA $0.53 Dividend yield N/A
200-day MA $0.93 Market Cap 61.34M

EyePoint Pharmaceuticals, Inc. (EYPT) Company Bio


EyePoint Pharmaceuticals (formerly pSivida Corp.) develops sustained-release drug-delivery products for treating eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior uveitis. The company was founded in 1987 and is based in Watertown, Massachusetts.


EYPT Latest News Stream


Event/Time News Detail
Loading, please wait...

EYPT Latest Social Stream


Loading social stream, please wait...

View Full EYPT Social Stream

Latest EYPT News From Around the Web

Below are the latest news stories about EyePoint Pharmaceuticals Inc that investors may wish to consider to help them evaluate EYPT as an investment opportunity.

The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 3) Akouos Inc (NASDAQ: AKUS ) FibroGen Inc (NASDAQ: FGEN )(reacted to an adverse clinical readout for a rival drug to treat chronic kidney disease related anemia) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Sutro Biopharma Inc (NASDAQ: STRO ) ( reacted to announcement concerning presentation of positive data for ovarian cancer drug) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 3) Akebia Therapeutics Inc (NASDAQ: AKBA ) (announced negative safety results for a late-stage study of drug to treat chronic kidney disease-induced anemia) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Genfit SA (NASDA...

Benzinga | September 4, 2020

The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (NASDAQ: CDMO ) ( reacted to strong quarterly results) BioLife Solutions Inc (NASDAQ: BLFS ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Edwards Lifesciences Corp (NYSE: EW ) Evogene Ltd (NASDAQ: EVGN ) Fortress Biotech (NASDAQ: FBIO ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) (priced its 5.27-million-share common stock offering at $33 per share) Inspire Medical Systems Inc (NYSE: INSP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp ...

Benzinga | September 3, 2020

EyePoint Pharma slips 7% on Dexcyu deal

EyePoint Pharmaceuticals (EYPT) has entered into a purchase and marketing agreement for Dexcyu (dexamethasone intraocular suspension) 9% with Vantage Outsourcing, a cataract surgical service provider to a variety of hospitals, ambulatory surgery centers and physicians.The agreement will enable customers in the Vantage Outsourcing network, which spans over a 25+ state service...

Seeking Alpha | August 24, 2020

EyePoint Pharmaceuticals News: Why EYPT Stock Is Soaring 21% Today

EyePoint Pharmaceuticals (EYPT) news from yesterday concerning a massive deal has EYPT stock continuing to climb higher on Friday.

InvestorPlace | August 21, 2020

34 Stocks Moving in Friday's Pre-Market Session

Gainers EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares rose 94.8% to $1.12 in pre-market trading. Eyepoint Pharmaceuticals shares gained around 11% on …

Benzinga | August 21, 2020

Read More 'EYPT' Stories Here

EYPT Price Returns

1-mo -13.74%
3-mo -36.95%
6-mo -50.65%
1-year -79.09%
3-year -61.67%
5-year -88.08%
YTD -70.32%
2019 -17.99%
2018 75.00%
2017 -36.84%
2016 -64.52%
2015 17.27%

Continue Researching EYPT

Here are a few links from around the web to help you further your research on EyePoint Pharmaceuticals Inc's stock as an investment opportunity:

EyePoint Pharmaceuticals Inc (EYPT) Stock Price | Nasdaq
EyePoint Pharmaceuticals Inc (EYPT) Stock Quote, History and News - Yahoo Finance
EyePoint Pharmaceuticals Inc (EYPT) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8908 seconds.